Edwards Lifesciences (EW) Cash from Operations (2009 - 2026)

Edwards Lifesciences' Cash from Operations history runs 18 years deep, the most recent figure standing at 43800000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 84.38% year-over-year to 43800000.0; the TTM figure through Mar 2026 stood at 1358600000.0 (up 55.06% YoY), while the FY2025 annual figure was 1595200000.0, up 194.15% from the prior year.
• Cash from Operations was 43800000.0 for Q1 2026 at Edwards Lifesciences, down from 450900000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 573700000.0 in Q3 2025 to a low of 127500000.0 in Q4 2024.
• Historically, Cash from Operations has averaged 252664705.88 across 5 years, with a median of 293300000.0 in 2022.
• Biggest YoY gain for Cash from Operations was 1005.65% in 2024; the steepest drop was 193.34% in 2024.
• A 5-year view of Cash from Operations shows it stood at 282800000.0 in 2022, then sank by 51.7% to 136600000.0 in 2023, then tumbled by 193.34% to 127500000.0 in 2024, then jumped by 453.65% to 450900000.0 in 2025, then plunged by 90.29% to 43800000.0 in 2026.
• The last three Cash from Operations figures came in at 43800000.0 (Q1 2026), 450900000.0 (Q4 2025), and 573700000.0 (Q3 2025), per Business Quant data.